- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03024541
Longitudinal Analysis of Drug Burden Index
January 13, 2017 updated by: Katja Taxis, University of Groningen
Longitudinal Analysis of Cumulative Exposure to Anticholinergic and Sedative Drugs Measured With the Drug Burden Index
Anticholinergic and sedative drugs are frequently prescribed to older people, despite their negative impact on older people's physical and cognitive function.
To estimate the cumulative exposure to anticholinergic and sedative drugs, Hilmer et al. published the Drug Burden Index (DBI) in 2007.
The present study aims to complement previous study findings showing higher DBI values to be associated with physical and cognitive impairment.
Most previously conducted studies of the DBI were either cross-sectional or were longitudinal but with short follow-ups.
Furthermore, it remains unknown whether higher DBI values carry extra risks for patients with dementia.
Finally, relatively little is known about the stability of DBI values over time.
The current project therefore aims to examine (1) longitudinal relationships between long-term cumulative exposure to anticholinergic and sedative drugs as measured with the DBI and cognitive and physical function, (2) to examine interaction effects between DBI exposure and dementia, and (3) to examine trajectories of DBI exposure, i.e.
DBI exposure remaining stable, declining, increasing or fluctuating over time.
These project aims will be studied with longitudinal data from eligible participants > 60 years from the LASA study with participants being followed-up during two decades, and the longitudinal data from the InterRAI consortium.
Various clinical outcomes regarding cognitive and physical function will be studied.
Data will be analysed with generalised linear mixed models and Latent Class Growth Analysis.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
9985
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
People aged 55 years and older, both community-dwelling individuals and individuals living in residential aged care facilities
Description
LASA:
Inclusion criteria:
- 55 years and older
Exclusion criteria:
- problem drinkers in the past and the present
- very severe vision and hearing problems
InterRAI:
Inclusion criteria:
- 55 years or older
Exclusion criteria:
- consumption of 5 or more units of alcohol on one occasion
- unknown sex or age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
LASA study
|
InterRAI consortium
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
LASA study: Alphabet Coding Task
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
LASA study: Mini Mental Status Examination
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
LASA study: Verbal Fluency Test: Phonemic fluency
Time Frame: collected at 7th wave after 21 years (cross-sectional)
|
collected at 7th wave after 21 years (cross-sectional)
|
LASA study: Verbal Fluency Test: Semantic fluency
Time Frame: collected at 7th wave after 21 years (cross-sectional)
|
collected at 7th wave after 21 years (cross-sectional)
|
LASA study: Digit Span Forward from Wechsler Adult Intelligence Scale
Time Frame: collected at 7th wave after 21 years (cross-sectional)
|
collected at 7th wave after 21 years (cross-sectional)
|
LASA study: Digit Span Backward from Wechsler Adult Intelligence Scale
Time Frame: collected at 7th wave after 21 years (cross-sectional)
|
collected at 7th wave after 21 years (cross-sectional)
|
LASA study: 15-Words Test: Word Learning
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
LASA study: 15-Words Test: Delayed Recall
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
LASA study: Functional Independence Scale
Time Frame: 18 years: 6 waves with 3 year intervals
|
18 years: 6 waves with 3 year intervals
|
LASA study: Chair Stands Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
LASA study: Walking Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
LASA study: Cardigan Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
LASA study: Balance Test
Time Frame: 21 years: 7 waves separated by 3 year intervals
|
21 years: 7 waves separated by 3 year intervals
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
InterRAI: Cognitive Performance Scale
Time Frame: 16 months
|
16 months
|
InterRAI: ADL Hierarchy Scale
Time Frame: 16 months
|
16 months
|
InterRAI: Timed 4 meter Walk Test
Time Frame: 16 months
|
16 months
|
InterRAI: Distance walked in past 3 days
Time Frame: 16 months
|
16 months
|
InterRAI: Hours of physical activity in past 3 days
Time Frame: 16 months
|
16 months
|
InterRAI: Days of coming outside in past 3 days
Time Frame: 16 months
|
16 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
October 18, 2016
First Submitted That Met QC Criteria
January 13, 2017
First Posted (Estimate)
January 19, 2017
Study Record Updates
Last Update Posted (Estimate)
January 19, 2017
Last Update Submitted That Met QC Criteria
January 13, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- DBI InterRAI LASA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Not Applicable: Permission to use the data should be obtained from the LASA and/or InterRAI researchers
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Function
-
University School of Physical Education in WroclawActive, not recruitingCognitive Function | Executive FunctionPoland
-
Maastricht UniversityWageningen University and Research; Top Institute Food and Nutrition; Netherlands...TerminatedCognitive Function | Ageing | Physical Function | Mitochondrial FunctionNetherlands
-
University Hospital, GenevaCompletedCognitive Function | Falls | Physical FunctionSwitzerland
-
University of FloridaNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedCognitive Function | Older Adults | Physical FunctionUnited States
-
Columbia UniversityNational Institute on Aging (NIA)Terminated
-
Örebro University, SwedenNot yet recruiting
-
Radicle ScienceActive, not recruitingCognitive FunctionUnited States
-
Vanderbilt University Medical CenterCompletedCognitive Function
-
Maastricht University Medical CenterBioActor B.V.Completed
-
University of OstravaCompletedCognitive FunctionCzechia